Navigation Links
Declaring War on Severe Asthma-COPD Overlap Syndrome
Date:5/6/2013

FOLSOM, Calif., May 6, 2013 /PRNewswire-iReach/ -- War has been declared on Severe Asthma-COPD Overlap Syndrome (ACOS). It's tied in with recognition of World Asthma Day May 7, 2013.

The World Asthma Foundation (WAF) is leading the charge to raise awareness and to elevate the discussion about this highly prevalent but terribly underappreciated ACOS syndrome.

ACOS, which was formerly called "asthmatic bronchitis," is a commonly experienced, yet loosely defined clinical entity. It accounts for approximately 15 to 25 percent of the general population with obstructive airway diseases who experience more severe outcomes compared to asthma or COPD alone.

The prevalence of frequent exacerbations in ACOS is nearly two-and-a-half times higher than COPD and risk of severe exacerbations in ACOS is twice as high as COPD. However, standard treatment options are not as aggressive as needed to treat the asthma-COPD syndrome.

"ACOS is concerning because it's much worse in terms of exacerbations, or acute attacks of breathlessness, as compared to COPD." said Amir Zeki , MD, assistant professor of medicine pulmonary, critical, and sleep medicine at the Center for Comparative Respiratory Biology and Medicine at the University of California Davis School Of Medicine and World Asthma Foundation Board Member.

"We are entering a new era of public awareness of people living with chronic lung disease such as asthma and COPD," said Sam Louie , MD and professor of medicine, director of the UC Davis Asthma Network (UCAN), director of the UC Davis Reversible Obstructive Airway Disease (ROAD) Center, which serves adults and adolescents in Northern California who have difficult to control asthma, bronchiectasis and COPD.

"Our mission at UC Davis is to transform health care by integrating and provide quality patient care services these conditions, which promote patient education and safety, social networking, and to align our goals with national efforts to transform people's lives," Louie said. "But we can achieve success without recognizing the clear and present danger from not being aware of the Asthma-COPD Overlap syndrome."

"It really all begins with empathy." Louie said. "Empathy of healthcare providers for how asthma, COPD and ACOS patients suffer when they are given prescription drugs without education on an individual level. We have to ignite that empathy by increasing awareness and providing education."

The two physicians are board members of the World Asthma Foundation, which provides educational resources that inform patients, medical professionals and the general public about the latest clinical advances, management and treatment options for asthma disorders, including ACOS.

"People with asthma, COPD and ACOS deserve better," Louie said. "It requires that we all take responsibility, patients too, but physicians must take their empathy one step further and realize how reversible asthma, COPD and ACOS can be."

William Cullifer , executive director of the World Asthma Foundation, said, "This is a fascinating new development in the understanding of asthma and COPD and it's fantastic to be on the forefront of educating the public and the healthcare community about this issue."

Louie added, "When you get done taking care of the disease, you're taking care of people. We must fight indifference and the only way to do that is to get the word out that we all have much more to achieve together to empower patients with reversible obstructive airway diseases."

For more information visit: http://worldasthmafoundation.org

Media Contact: William Cullifer World Asthma Foundation, 916 790-1166, bill@worldasthmafoundation.org

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE World Asthma Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Surveyed U.S. Pulmonologists Expect to Treat Nearly 50 Percent of Their Severe, Refractory Asthma Patients With a Biologic or Biosimilar Version of Xolair By the End of 2018
2. Defective Medicare Bidding Program For Medical Equipment Forces Severe Hardships On California Business Owners And Beneficiaries
3. Catabasis Initiates Phase 1 Trial of CAT-2003 for Treatment of Severe Hypertriglyceridemia
4. Sanofi US Offers a New Way to Say "Thank You" and Recognize the Unsung Heroes of Severe Allergy Awareness
5. Isis Pharmaceuticals Reports Clinical Data Showing Blunting of Severe Increases in CRP Following Endotoxin Challenge With ISIS-CRP Rx
6. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
7. First U.S. Patients Treated in PneumRx RENEW Pivotal Study for Treatment of Severe Emphysema
8. Unilife Corporation Reschedules Release Of Quarterly Results And Earnings Call Due To Severe Weather In Northeastern U.S.
9. Lilly Supports Research to Determine What a Dogs Nose Knows About People with Diabetes and Severe Hypoglycemia
10. Albireo Receives Positive Opinion for Orphan Drug Designation for A4250 for Severe Liver Diseases
11. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... New York , April 27, 2016 ... market report titled, "Skincare Devices Market - Global Industry ... 2023." According to the report, the global skincare devices ... and is anticipated to expand at a CAGR of ... Mn in 2023. Browse the full Skincare Devices ...
(Date:4/27/2016)... 27, 2016 Research ... "Global Anesthesia Disposables Market 2016-2020"  report to ... ) ,The global anesthesia disposables market is ... 4.03% during the period 2016-2020.  ... to patients, safety. Organizations like the CDC ...
(Date:4/26/2016)... 2016 Diplomat Pharmacy, Inc. (NYSE: DPLO) is ... , Pharm D., to Vice President of Education and ... Hagerman will continue to lead and oversee Diplomat University, ... education and training to Diplomat employees and external professionals ... University also houses the quality assurance department, which focuses ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that ... head and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to ... AIRWAY™ is a newly patented safety device secured by nasal surgeons onto the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the ... of funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... base and accelerate its technology and product roadmap. , “Jvion is ...
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions ... to Work employee satisfaction survey, earning them second place for Tampa’s Best Places to ... employees. , “This is a great accomplishment for our team,” says RMS Human ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at ... Sanaz Ghazal, and Dr. Daniel A. Potter -- are proud of the recent release ... Technology (SART). In April, SART published the latest verified data for 375 ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... their animal line of probiotics, Petbiotics ™, as they fondly call them. ... animal rescue groups networking for their non-profit organizations. Animal rescues across the nation ...
Breaking Medicine News(10 mins):